Fukuda T, Ishii K, Nanmoku T, Isobe K, Kawakami Y, Takekoshi K
Molecular Laboratory Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
J Neuroendocrinol. 2007 Aug;19(8):621-31. doi: 10.1111/j.1365-2826.2007.01570.x.
The activity of AMP-activated protein kinase (AMPK) is regulated by the metabolic and nutritional state of the cell. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) is transformed into riboside monophosphate (ZMP) via phosphorylation by adenosine kinase inside the cell and exerts it effect by stimulating AMPK. AICAR significantly induces an increase in AMPK activity in a dose- and time-dependent manner in the rat pheochromocytoma cell line PC12. In addition, compound C, an AMPK inhibitor, as well as 5'-amino-5'-dAdo, an adenosine kinase inhibitor, inhibits the AICAR-induced AMPK activity. AICAR significantly stimulates tyrosine hydroxylase (TH) (the rate-limiting enzyme in the biosynthesis of catecholamine) activity and the corresponding mRNA level, which closely matches with the TH protein level. In addition, AICAR provokes a rapid and long-lasting increase in the phosphorylation of TH at Ser19, Ser31 and Ser40. AICAR also markedly activates ERKs, JNK and p38. The MEK-1-inhibitor (PD-098059) causes a partial, but significant, inhibition of AICAR-induced TH enzyme activity by phosphorylation of Ser31 without affecting phosphorylation at the two other sites. By contrast, neither the JNK-inhibitor nor the p38-inhibitor affects TH enzyme activity and phosphorylation. Similarly, PD-098059 partially, but significantly, inhibits the AICAR-induced increase in the TH mRNA level. Furthermore, AICAR increases the level of cAMP in PC12 cells. The present study also shows that H89, a protein kinase A inhibitor, abolishes the AICAR-induced increase in the level of TH mRNA, as well as the corresponding enzyme activity and Ser40 phosphorylation. Finally, AICAR significantly increases dopamine secretion from PC12 cells. These findings indicate that AICAR activates catecholamine synthesis and secretion through AMPK activation in chromaffin cells.
AMP激活的蛋白激酶(AMPK)的活性受细胞的代谢和营养状态调节。5-氨基咪唑-4-甲酰胺-1-β-D-呋喃核糖苷(AICAR)在细胞内通过腺苷激酶磷酸化转化为单磷酸核糖苷(ZMP),并通过刺激AMPK发挥作用。AICAR在大鼠嗜铬细胞瘤细胞系PC12中以剂量和时间依赖性方式显著诱导AMPK活性增加。此外,AMPK抑制剂化合物C以及腺苷激酶抑制剂5'-氨基-5'-脱氧腺苷抑制AICAR诱导的AMPK活性。AICAR显著刺激酪氨酸羟化酶(TH)(儿茶酚胺生物合成中的限速酶)活性和相应的mRNA水平,这与TH蛋白水平密切匹配。此外,AICAR引起TH在Ser19、Ser31和Ser40位点的磷酸化迅速且持久增加。AICAR还显著激活细胞外信号调节激酶(ERK)、应激活化蛋白激酶(JNK)和p38。MEK-1抑制剂(PD-098059)通过Ser31磷酸化对AICAR诱导的TH酶活性产生部分但显著的抑制作用,而不影响其他两个位点的磷酸化。相比之下,JNK抑制剂和p38抑制剂均不影响TH酶活性和磷酸化。同样,PD-098059部分但显著地抑制AICAR诱导的TH mRNA水平增加。此外,AICAR增加PC12细胞中cAMP的水平。本研究还表明,蛋白激酶A抑制剂H89消除了AICAR诱导的TH mRNA水平增加以及相应的酶活性和Ser40磷酸化。最后,AICAR显著增加PC12细胞中多巴胺的分泌。这些发现表明,AICAR通过激活嗜铬细胞中的AMPK来激活儿茶酚胺的合成和分泌。